James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 4,000 shares at $25.00 ($90K) on 2025-05-16, disclosed to the SEC on 2025-05-19.
Scheduled sale ($90k) by PRINCIPAL ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 2,000 | $40K | 44.4% |
| 2 | $25.00 | 2,000 | $50K | 55.6% |
| Total | $22.50 avg | 4,000 | $90K | 100% |
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |